Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects

Inclusion Criteria: * Hospitalized Japanese descent subjects known or suspected to have CAP with a severity that requires IV antibiotic treatment. * Chest radiograph within 48 hours before the first dose of IV test article showing the presence of a new infiltrate. * The presence of fever or hypothermia within 24 hours before the first administration of test article, and of at least two signs/symptoms of CAP within 24 hours before the first administration of test article. Exclusion Criteria: * Any concomitant condition that, in the opinion of the investigator, would preclude an evaluation of a response or make it unlikely that the contemplated course of therapy could be completed. * Hospital-acquired pneumonia, other lung disease including viral, fungal, or parasitic pneumonia, immunosuppressive conditions, and other illness, which affect evaluation of safety and efficacy of tigecycline. * Known or suspected hypersensitivity to tigecycline or tetracyclines, or contraindication for these antibiotics.